Evidence map›Paper›PMID 28209809›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.

Ying-Ying Wang, Hong Jiang, Jun Pan, Xiao-Ru Huang, Yu-Cheng Wang, Hong-Feng Huang, Ka-Fai To, David J Nikolic-Paterson, Hui-Yao Lan, Jiang-Hua Chen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 268 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 3 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 3 syntheses or guidelines pooled it, 412 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Comparative Study ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  18. Inhibition of (interstitial) P2YPflugers Archiv : European journal of physiology · 2026
    Article
  19. Article
  20. Article

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ying-Ying WangKidney Disease Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Hong JiangKidney Disease Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jun PanDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and The Chinese University of Hong Kong, Shenzhen Research Institute, and.
Xiao-Ru HuangDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and The Chinese University of Hong Kong, Shenzhen Research Institute, and.
Yu-Cheng WangKidney Disease Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Hong-Feng HuangKidney Disease Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Ka-Fai ToDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China; and.
David J Nikolic-PatersonDepartment of Nephrology, Monash Medical Center and Monash University Department of Medicine, Clayton, Melbourne, Australia.
Hui-Yao LanDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and The Chinese University of Hong Kong, Shenzhen Research Institute, and hylan@cuhk.edu.hk chenjianghua@zju.edu.cn.
Jiang-Hua ChenKidney Disease Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, hylan@cuhk.edu.hk chenjianghua@zju.edu.cn.
Zhejiang University · CNChinese University of Hong Kong, Shenzhen · CNChinese University of Hong Kong · CNMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial fibrosis is an important contributor to graft loss in chronic renal allograft injury. Inflammatory macrophages are associated with fibrosis in renal allografts, but how these cells contribute to this damaging response is not clearly understood. Here, we investigated the role of macrophage-to-myofibroblast transition in interstitial fibrosis in human and experimental chronic renal allograft injury. In biopsy specimens from patients with active chronic allograft rejection, we identified cells undergoing macrophage-to-myofibroblast transition by the coexpression of macrophage (CD68) and myofibroblast (

Indexed as

Kidney TransplantationAllograftsAnimalsCell TransdifferentiationChronic DiseaseFemaleFibrosisHumansKidneyKidney DiseasesMacrophagesMaleMiceMice, Inbred C57BLMyofibroblastsPostoperative Complicationschronic allograft rejectioninterstitial fibrosislineage tracingM2 macrophagemacrophage myofibroblast transitionSmad3

Identifiers

PMID28209809
PMCPMC5491278
OpenAlexW2589113597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.